ATE98649T1 - Reinigung von lfa-3. - Google Patents

Reinigung von lfa-3.

Info

Publication number
ATE98649T1
ATE98649T1 AT88301709T AT88301709T ATE98649T1 AT E98649 T1 ATE98649 T1 AT E98649T1 AT 88301709 T AT88301709 T AT 88301709T AT 88301709 T AT88301709 T AT 88301709T AT E98649 T1 ATE98649 T1 AT E98649T1
Authority
AT
Austria
Prior art keywords
lfa
cleaning
quantitating
purifying
useful
Prior art date
Application number
AT88301709T
Other languages
English (en)
Inventor
Michael Dustin
Timothy Springer
Original Assignee
Dana Farber Cancer Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Inst Inc filed Critical Dana Farber Cancer Inst Inc
Application granted granted Critical
Publication of ATE98649T1 publication Critical patent/ATE98649T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70528—CD58
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2806—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2824—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD58
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Removal Of Specific Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT88301709T 1987-02-26 1988-02-26 Reinigung von lfa-3. ATE98649T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1901087A 1987-02-26 1987-02-26
EP88301709A EP0280578B1 (de) 1987-02-26 1988-02-26 Reinigung von LFA-3

Publications (1)

Publication Number Publication Date
ATE98649T1 true ATE98649T1 (de) 1994-01-15

Family

ID=21790939

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88301709T ATE98649T1 (de) 1987-02-26 1988-02-26 Reinigung von lfa-3.

Country Status (6)

Country Link
EP (1) EP0280578B1 (de)
JP (1) JPS63276494A (de)
AT (1) ATE98649T1 (de)
CA (1) CA1326940C (de)
DE (1) DE3886237T2 (de)
ES (1) ES2061638T3 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185441A (en) * 1988-08-26 1993-02-09 Biogen, Inc. Dna sequences, recombinant dna molecules and processes for producing pi-linked lymphocyte function associated antigen-3
DE68929096T2 (de) 1988-09-01 2000-05-11 Bayer Corp., Pittsburgh Menschliches Rhinovirusrezeptorprotein, das die Virusinfektionsanfälligkeit hemmt
US6514936B1 (en) 1988-09-01 2003-02-04 Bayer Corporation Antiviral methods using human rhinovirus receptor (ICAM-1)
US6143298A (en) * 1988-09-01 2000-11-07 Bayer Corporation Soluble truncated forms of ICAM-1
ZA896668B (en) * 1988-09-01 1990-06-27 Molecular Therapeutics Inc A human rhinovirus receptor protein that inhibits virus infectivity
US6051231A (en) * 1988-09-01 2000-04-18 Bayer Corporation Antiviral methods and prepations
JPH02262599A (ja) * 1989-01-03 1990-10-25 Merck & Co Inc ヒト多形核白血球からの精製Ｃ５ａレセプター
US6107461A (en) * 1990-07-20 2000-08-22 Bayer Corporation Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use
EP0468257B1 (de) * 1990-07-20 1999-09-01 Bayer Corporation Multimere Formen des menschlichen Rhinovirus-Rezeptorproteins
US5686582A (en) * 1990-07-20 1997-11-11 Bayer Corporation Multimeric forms of human rhinovirus receptor protein
US5674982A (en) * 1990-07-20 1997-10-07 Bayer Corporation Multimeric form of human rhinovirus receptor protein
EP0503646A1 (de) * 1991-03-12 1992-09-16 Biogen, Inc. Monoklonale Antikörper gegen Lymphozytenfunktionassoziertes Antigen-3
US6162432A (en) * 1991-10-07 2000-12-19 Biogen, Inc. Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction
US6764681B2 (en) 1991-10-07 2004-07-20 Biogen, Inc. Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction
EP0786255B1 (de) * 1991-10-07 2001-12-12 Biogen, Inc. Verfahren zur Verbesserung der Toleranz für Allotransplantaten und Xenotransplantaten durch Verabreichung eines LFA-3- oder CD2-Bindungsproteins
US7858095B2 (en) 2001-07-24 2010-12-28 Astellas Us Llc Method for treating or preventing sclerotic disorders using CD-2 binding agents
CA2565259A1 (en) 2004-05-07 2005-12-08 Astellas Us Llc Soluble lfa-3 polypeptide for treating viral disorders
SG10201908027QA (en) 2015-03-13 2019-10-30 Bristol Myers Squibb Co Use of alkaline washes during chromatography to remove impurities

Also Published As

Publication number Publication date
JPS63276494A (ja) 1988-11-14
ES2061638T3 (es) 1994-12-16
CA1326940C (en) 1994-02-08
EP0280578A2 (de) 1988-08-31
DE3886237T2 (de) 1994-05-05
DE3886237D1 (de) 1994-01-27
EP0280578A3 (en) 1989-03-29
EP0280578B1 (de) 1993-12-15

Similar Documents

Publication Publication Date Title
ATE98649T1 (de) Reinigung von lfa-3.
EP0391526A3 (de) Reinigungsverfahren für Antikörper
DE3773523D1 (de) Verfahren zum abscheiden von kohlenstoffmonoxid konstanter reinheit.
BR9002017A (pt) Acido 2-0-.-d-glicopiranosil-i-ascorbico cristalino,processo de sua preparacao,e seus usos
BR8704282A (pt) Separacao por adsorcao de misturas gasosas
GB8728326D0 (en) Separation & purification of cyclodextrins
DE3583043D1 (de) Verfahren zur reinigung von podophyllotoxin.
KR890700609A (ko) 정제된 혈소판으로 부터 유도한 성장 인자 및 그의 정제방법
FI103974B1 (fi) Menetelmä proteiinin puhdistamiseksi
ES2019127B3 (es) Proceso de purificacion destilativa de tetrahidrofurano
EP0603671A3 (de) Verfahren zur Reaktivierung von gereinigten Membranproteinen.
DK443586A (da) Vandrensningsproces
DE68908801D1 (de) Verfahren zur Reinigung von Dihydroxyphenolen.
ATE76082T1 (de) Reinigungsmethode fuer antikoerper.
PT85956A (en) Process for protein purification
BR8502841A (pt) Processo de purificacao de mercaptobenzotiazola
FR2559153B1 (fr) Procede de purification d'oxacephalosporines
AU571713B2 (en) Method of purification of lpf-ha from bordetella pertussis
PL265054A1 (en) Method for purification of 1,2,3,5-tetracyanbenzene
DE68918436D1 (de) Adsorptives Trennungsverfahren zur Reinigung von 2,6-Dimethylnaphthalin.
OA08918A (fr) Procédé d'enrichissement de la canallite par flottation.
NO175145C (no) Fremgangsmåte for rensing av 2,2',4,4',6,6'-hexnanitrostilben(HNS)
ATE63916T1 (de) Verfahren zur reinigung von podophyllotoxin.
SE8603414D0 (sv) Separeringsprocess 2
HUT34547A (en) Process for the purification of proteins isolated from microbe cultures

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee